Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment is on the horizon

The psychedelic treatment is moving through the FDA clinical trial process in Colorado and elsewhere.

By: Camille Hoffman, University of Colorado Anschutz, The Conversation

Outlets: The Conversation

Published: July 7, 2026

Words: 1,424

Last Updated: 2 weeks ago

By Camille Hoffman, University of Colorado Anschutz

About 1 in 5 women will experience depression and anxiety during pregnancy or in the year after giving birth. If untreated, a mother who has these conditions has a higher risk of birth complications, overall poorer health, impaired bonding and nurturing of her infant, and a higher risk of death by suicide.

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.